Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Dynavax Technologies Corporation - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
DVAX
Nasdaq
2830
www.dynavax.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Dynavax Technologies Corporation
Wall Street Analysts See an 83.1% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High?
- Mar 12th, 2025 1:55 pm
Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors
- Mar 10th, 2025 12:00 pm
Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase
- Mar 6th, 2025 11:00 am
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?
- Mar 5th, 2025 2:40 pm
Is Dynavax Technologies Corporation (DVAX) the Best Small Cap Pharma Stock to Buy Now?
- Mar 2nd, 2025 5:36 pm
Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest
- Feb 28th, 2025 10:43 am
Dynavax to Participate in Upcoming Investor Conferences
- Feb 25th, 2025 9:10 pm
Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet
- Feb 24th, 2025 2:55 pm
Dynavax Technologies Full Year 2024 Earnings: EPS Misses Expectations
- Feb 22nd, 2025 12:55 pm
MercadoLibre Stock Hits New High As Company Delivers Profits
- Feb 21st, 2025 5:59 pm
Dynavax Technologies Corp (DVAX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
- Feb 21st, 2025 7:14 am
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript
- Feb 21st, 2025 2:30 am
Dynavax Technologies (DVAX) Surpasses Q4 Earnings and Revenue Estimates
- Feb 20th, 2025 10:10 pm
Dynavax Technologies: Q4 Earnings Snapshot
- Feb 20th, 2025 9:15 pm
Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance
- Feb 20th, 2025 9:01 pm
High Growth Tech Stocks To Watch In February 2025
- Feb 20th, 2025 6:02 pm
Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy
- Feb 19th, 2025 9:52 pm
Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
- Feb 19th, 2025 2:00 pm
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors
- Feb 19th, 2025 1:04 pm
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
- Feb 11th, 2025 8:11 pm
Scroll